We also identified other upstream regulator of NF-κB including ERK (PD98059) and AKT (LY294002) on NSCLC; however, PKC-δ inhibitor (rottlerin) showed greater NF-κB suppression capacity (Supplementary Figure). This evidence concerns the gene AKT1 and non-small cell lung carcinoma.